Johnson Financial Group Inc (Wisconsin)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $157K | Sell |
1,738
-61
| -3% | -$5.11K | 0.01% | 343 |
|
|
2026
Q1 | $144K | Hold |
1,799
| – | – | 0.01% | 361 |
|
|
2025
Q4 | $153K | Buy |
1,799
+476
| +36% | +$39.1K | 0.01% | 360 |
|
|
2025
Q3 | $103K | Buy |
1,323
+104
| +9% | +$8.13K | ﹤0.01% | 450 |
|
|
2025
Q2 | $95.3K | Hold |
1,219
| – | – | ﹤0.01% | 382 |
|
|
2025
Q1 | $88.4K | Hold |
1,219
| – | – | ﹤0.01% | 509 |
|
|
2024
Q4 | $88.3K | Sell |
1,219
-92
| -7% | -$6.44K | ﹤0.01% | 388 |
|
|
2024
Q3 | $86.5K | Sell |
1,311
-234
| -15% | -$17K | ﹤0.01% | 461 |
|
|
2024
Q2 | $143K | Buy |
1,545
+774
| +100% | +$68.5K | 0.01% | 346 |
|
|
2024
Q1 | $73.7K | Hold |
771
| – | – | ﹤0.01% | 384 |
|
|
2023
Q4 | $58.8K | Buy |
771
+144
| +23% | +$10K | ﹤0.01% | 434 |
|
|
2023
Q3 | $43.4K | Hold |
627
| – | – | ﹤0.01% | 410 |
|
|
2023
Q2 | $59.1K | Sell |
627
-161
| -20% | -$14K | ﹤0.01% | 391 |
|
|
2023
Q1 | $65.2K | Buy |
788
+161
| +26% | +$12.7K | ﹤0.01% | 376 |
|
|
2022
Q4 | $46.8K | Hold |
627
| – | – | ﹤0.01% | 353 |
|
|
2022
Q3 | $45K | Sell |
627
-1,392
| -69% | -$134K | ﹤0.01% | 359 |
|
|
2022
Q2 | $192K | Hold |
2,019
| – | – | 0.01% | 250 |
|
|
2022
Q1 | $238K | Hold |
2,019
| – | – | 0.02% | 253 |
|
|
2021
Q4 | $262K | Hold |
2,019
| – | – | 0.02% | 247 |
|
|
2021
Q3 | $229K | Hold |
2,019
| – | – | 0.02% | 251 |
|
|
2021
Q2 | $209K | Hold |
2,019
| – | – | 0.01% | 266 |
|
|
2021
Q1 | $169K | Sell |
2,019
-899
| -31% | -$76K | 0.01% | 280 |
|
|
2020
Q4 | $266K | Buy |
2,918
+899
| +45% | +$74.6K | 0.02% | 195 |
|
|
2020
Q3 | $161K | Hold |
2,019
| – | – | 0.02% | 202 |
|
|
2020
Q2 | $140K | Hold |
2,019
| – | – | 0.02% | 199 |
|
|
2020
Q1 | $127K | Hold |
2,019
| – | – | 0.02% | 220 |
|
|
2019
Q4 | $157K | Hold |
2,019
| – | – | 0.01% | 228 |
|
|
2019
Q3 | $148K | Hold |
2,019
| – | – | 0.01% | 248 |
|
|
2019
Q2 | $124K | Hold |
2,019
| – | – | 0.01% | 257 |
|
|
2019
Q1 | $129K | Sell |
2,019
-150
| -7% | -$8.56K | 0.01% | 249 |
|
|
2018
Q4 | $111K | Hold |
2,169
| – | – | 0.01% | 252 |
|
|
2018
Q3 | $126K | Hold |
2,169
| – | – | 0.01% | 244 |
|
|
2018
Q2 | $105K | Sell |
2,169
-168
| -7% | -$7.84K | 0.01% | 261 |
|
|
2018
Q1 | $109K | Sell |
2,337
-3,900
| -63% | -$169K | 0.01% | 262 |
|
|
2017
Q4 | $234K | Hold |
6,237
| – | – | 0.03% | 229 |
|
|
2017
Q3 | $227K | Buy |
6,237
+1,320
| +27% | +$50.3K | 0.03% | 221 |
|
|
2017
Q2 | $194K | Buy |
4,917
+327
| +7% | +$11.9K | 0.03% | 237 |
|
|
2017
Q1 | $144K | Sell |
4,590
-225
| -5% | -$7.04K | 0.02% | 287 |
|
|
2016
Q4 | $150K | Sell |
4,815
-870
| -15% | -$28.2K | 0.02% | 296 |
|
|
2016
Q3 | $228K | Sell |
5,685
-1,167
| -17% | -$43.9K | 0.03% | 249 |
|
|
2016
Q2 | $228K | Sell |
6,852
-2,085
| -23% | -$71.3K | 0.03% | 270 |
|
|
2016
Q1 | $263K | Sell |
8,937
-8,574
| -49% | -$237K | 0.05% | 226 |
|
|
2015
Q4 | $461K | Sell |
17,511
-3,129
| -15% | -$81.3K | 0.1% | 171 |
|
|
2015
Q3 | $489K | Buy |
20,640
+12,780
| +163% | +$308K | 0.11% | 168 |
|
|
2015
Q2 | $186K | Buy |
7,860
+1,860
| +31% | +$42K | 0.04% | 262 |
|
|
2015
Q1 | $142K | Hold |
6,000
| – | – | 0.03% | 316 |
|
|
2014
Q4 | $127K | Hold |
6,000
| – | – | 0.03% | 318 |
|
|
2014
Q3 | $102K | Buy |
+6,000
| New | +$94.7K | 0.03% | 323 |
|
|
2013
Q4 | – | Sell |
-6,000
| Closed | -$70K | – | 702 |
|
|
2013
Q3 | $70K | Buy |
+6,000
| New | +$70.2K | 0.02% | 361 |
|
Other funds holding EW
Johnson Financial Group Inc (Wisconsin)'s EW Position: Q2 2026 in Review
Johnson Financial Group Inc (Wisconsin) reduced its Edwards Lifesciences (EW) stake by 3.4% in Q2 2026, selling an estimated $5.11K and leaving 1,738 shares worth $157K. The position accounts for 0.01% of the portfolio, ranked #343.
Johnson Financial Group Inc (Wisconsin) first reported a position in EW in Q3 2013 and has held it in 49 quarters since. The position peaked at $489K in Q3 2015. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Johnson Financial Group Inc (Wisconsin) held 1,738 shares of Edwards Lifesciences worth $157K as of Q2 2026.
- Johnson Financial Group Inc (Wisconsin) sold 61 Edwards Lifesciences shares in Q2 2026, an estimated $5.11K.
- Edwards Lifesciences made up 0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #343 holding.
- Johnson Financial Group Inc (Wisconsin) first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 49 quarters since.
- Johnson Financial Group Inc (Wisconsin)'s Edwards Lifesciences position peaked at $489K in Q3 2015.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.